missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ pVAX1 Vector
Specifically designed for use in the development of DNA vaccines
Supplier: Invitrogen™ V26020
Comprend: 20μg of each pVAX1 and expression control vector are supplied supercoiled and lyophilized.
Description
- Features eukaryotic DNA sequences limited to those required for expression in order to minimize possibility of chromosomal integration
- Kanamycin resistance gene for selection in E. coli because ampicillin has been reported to cause allergic response in some individuals
- Expression levels of recombinant proteins from pVAX1 comparable to those achieved with its parent vector, pcDNA™3.1
- Small size of pVAX1 and the variety of unique cloning sites simplify subcloning of even very large DNA fragments
Bioproduction, Constitutive Expression, Mammalian Expression, Protein Expression, Proteins, Expression, Isolation and Analysis, Viral Vaccine Production
Spécifications
| Constitutive | |
| CMV | |
| None | |
| Untagged | |
| 20 μg | |
| pVAX |
| Transfection | |
| Viral Vaccine Vector | |
| 20 μg of each pVAX1 and expression control vector are supplied supercoiled and lyophilized. Store at -20°C. Vector is guaranteed stable for 6 months when properly stored. | |
| Restriction Enzyme/MCS | |
| pVAX1 |
For Research Use Only. Not for use in diagnostic procedures.